Rafael (RFL) Stock Price, News & Analysis

Company Overview

Rafael Holdings, Inc. is a diversified holding company focused primarily on life sciences and real estate. Through its life sciences activities, the company has supported the development of therapies designed to address serious diseases, including cancer, with a particular emphasis on treatments that target cancer-cell metabolism.

The company’s real estate interests include commercial properties and related investments. Rafael Holdings has historically maintained a connection to Rafael Pharmaceuticals, a biotechnology company involved in oncology drug development, although its operating structure and investments may change over time.

Rafael Holdings was established as a spin-off from IDT Corporation. The company is based in the United States and serves its markets through its investment holdings rather than through a broad consumer-facing product portfolio.

Key Stats

• Today's Range: $1.50 to $1.62
• 50-Day Range: $1.33 to $2.60
• 52-Week Range: $1.12 to $3.96
• Volume: 93,914 shs
• Average Volume: 256,110 shs
• Market Capitalization: $83.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Rafael Stock Analysis - MarketRank™

Rafael scored higher than 10% of companies evaluated by MarketBeat, and ranked 841st out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Rafael has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Rafael has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Rafael is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Rafael is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Rafael has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.26% of the float of Rafael has been sold short.

Short Interest Ratio / Days to Cover

Rafael has a short interest ratio ("days to cover") of 2.29, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rafael has recently decreased by 0.27%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Rafael does not currently pay a dividend.

Dividend Growth

Rafael does not have a long track record of dividend growth.

News and Social Media

• Score: 1.0 / 5
• News Sentiment: -0.37

News Sentiment

Rafael has a news sentiment score of -0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Rafael this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added Rafael to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rafael insiders have not sold or bought any company stock.

Percentage Held by Insiders

32.90% of the stock of Rafael is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

11.30% of the stock of Rafael is held by institutions.

Company Calendar

• Last Earnings: 10/29/2025
• Today: 10/10/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 7/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NYSE:RFL
• CIK: 1713863
• Web: www.rafaelholdings.com
• Phone: (212) 658-1450
• Fax: N/A
• Employees: 23
• Year Founded: 2000

Profitability

• EPS (Trailing Twelve Months): ($0.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$30.52 million
• Net Margins: -3,321.74%
• Pretax Margin: -3,182.25%
• Return on Equity: -41.27%
• Return on Assets: -35.32%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.16
• Quick Ratio: 3.14

Sales & Book Value

• Annual Sales: $920 thousand
• Price / Sales: 91.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.91 per share
• Price / Book: 0.84

Miscellaneous

• Outstanding Shares: 52,000,000
• Free Float: 34,892,000
• Market Cap: $83.88 million
• Optionable: Optionable
• Beta: 0.35